Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABC.L Share News (ABC)

  • There is currently no data for ABC

Abcam acquires Marker Gene Technologies

Wed, 04th Mar 2020 10:26
(Sharecast News) - Life sciences group Abcam extended its assay and labelling capabilities on Wednesday with the acquisition of Marker Gene Technologies for an undisclosed sum.
Following Abcam's recent acquisition of Expedeon's proteomics and immunology business, the firm sought to give itself additional proprietary assay development technologies and labelling capabilities as part of its broader antibody-conjugation strategy.

The AIM-listed group said Marker Gene Technologies' team had expertise in the areas of biology, organic synthesis and fluorescence chemistry and were experienced in the creation of detection tools that enable "enhanced understanding of biological processes".

Abcam said the deal would only have a "minimal impact" on revenue and earnings in the current financial year.

As of 1025 GMT, Abcam shares were down 0.17% at 1,228.90p.

Related News

RBC Capital Markets downgrades Abcam to 'sector perform'
20 Jun 2023

RBC Capital Markets downgrades Abcam to 'sector perform'

(Sharecast News) - RBC Capital Markets downgraded Abcam on Tuesday to 'sector perform' from 'outperform' and cut the price target to $22 from $23 as i...

Broker tips: Ocado, Abcam
20 Jun 2023

Broker tips: Ocado, Abcam

(Sharecast News) - Online supermarket Ocado was under the cosh on Tuesday after JPMorgan Cazenove cut its price target on the shares to 400p from 450p...

Sunday newspaper round-up: Bank of England, Sturgeon, Melrose
11 Jun 2023

Sunday newspaper round-up: Bank of England, Sturgeon, Melrose

(Sharecast News) - Experts believe that the Bank of England will have to jack up its base rate from 4.5% at present to 5.5% by the end of 2023 in orde...

ABC.L News

RBC Capital Markets downgrades Abcam to 'sector perform'
20 Jun 2023

RBC Capital Markets downgrades Abcam to 'sector perform'

(Sharecast News) - RBC Capital Markets downgraded Abcam on Tuesday to 'sector perform' from 'outperform' and cut the price target to $22 from $23 as i...

Broker tips: Ocado, Abcam
20 Jun 2023

Broker tips: Ocado, Abcam

(Sharecast News) - Online supermarket Ocado was under the cosh on Tuesday after JPMorgan Cazenove cut its price target on the shares to 400p from 450p...

Sunday newspaper round-up: Bank of England, Sturgeon, Melrose
11 Jun 2023

Sunday newspaper round-up: Bank of England, Sturgeon, Melrose

(Sharecast News) - Experts believe that the Bank of England will have to jack up its base rate from 4.5% at present to 5.5% by the end of 2023 in orde...

Abcam delisting from AIM going ahead this week
12 Dec 2022

Abcam delisting from AIM going ahead this week

(Sharecast News) - Life science research tool specialist Abcam updated the market on the cancellation of its shares on AIM on Monday, which it first a...

TOP NEWS: AIM to lose largest listing as Abcam to trade only on Nasdaq
17 Oct 2022

TOP NEWS: AIM to lose largest listing as Abcam to trade only on Nasdaq

(Alliance News) - Abcam PLC on Monday proposed delisting from AIM in London and retaining a sole listing on Nasdaq in New York.

LONDON BRIEFING: Vodafone, Altice team; Hargreaves Lansdown CEO to go
17 Oct 2022

LONDON BRIEFING: Vodafone, Altice team; Hargreaves Lansdown CEO to go

(Alliance News) - Stocks in London are called a touch lower on Monday, though the pound was on the up, despite the prospect of more UK political uncer...

LONDON BROKER RATINGS: Stifel downgrades IAG, easyJet and Ryanair
14 Sep 2022

LONDON BROKER RATINGS: Stifel downgrades IAG, easyJet and Ryanair

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

IN BRIEF: Abcam interim profit falls by 20% as expenses rise
12 Sep 2022

IN BRIEF: Abcam interim profit falls by 20% as expenses rise

Abcam PLC - Cambridge-based life science research software firm - Posts lower profit for six months that ended June 30 as expenses increase. Pretax pr...